微RNA和长非编码RNA 在T细胞淋巴瘤中:机制,途径,治疗机会
Mohammed H Abu-Alghayth1, Adil Abalkhail2, Ali Hazazi3
1Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 255, Bisha 67714, Saudi Arabia.
Pathology, research and practice
|December 31, 2024
概括
T细胞淋巴瘤是由恶性T细胞增殖驱动的具有挑战性的癌症. RNA疗法为向治疗提供了一个有希望的新途径,解决了当前治疗方法的局限性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- T细胞淋巴瘤是非霍奇金淋巴瘤,其特征是不受控制的恶性T淋巴细胞增殖.
- 将亚型分类和理解生物机制仍然具有挑战性,EBV和HTLV-1等病毒可能发挥作用.
- 异常的基因表达和非编码RNA,包括微RNA (miRNA) 和长非编码RNA (lncRNA),都与T细胞淋巴瘤的发病有关.
研究的目的:
- 审查T细胞淋巴瘤的分类,病原和当前治疗策略.
- 探索非编码RNAs在T细胞淋巴瘤的发展和进展中的作用.
- 讨论基于RNA的疗法作为一种新型治疗方式的潜力.
主要方法:
- 使用PubMed,Springer Link,谷歌学者和科学网络进行系统的文献调查.
- 关键词包括"T细胞淋巴瘤"",治疗方法"",RNA疗法"",微RNA"和"信号通路".
- 对非编码RNA和新兴基于RNA的治疗策略的当前研究进行分析.
主要成果:
- 在T细胞淋巴瘤中,基因表达失调,miRNAs作为瘤抑制剂或瘤基因.
- lncRNAs调节基因表达和T细胞功能,呈现出潜在的治疗点.
- 虽然化疗是标准的,但免疫疗法和向疗法正在出现;然而,晚期或耐火病例带来了管理挑战.
结论:
- 基于RNA的疗法对T细胞淋巴瘤的向治疗有前途,提供个性化药物的潜力和减少副作用.
- 对于RNA疗法来说,必须解决传递,免疫反应和特异性的挑战,以达到它们的全部潜力.
- 未来的研究应该专注于优化输送系统,免疫调节和生产基于RNA的T细胞淋巴瘤疗法.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
73
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:27Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K